Press releasePRNewswire
Encompass Health
EHC · NYSE
$121.67−$0.04 (−0.03%)TodayMarket closed ·
Prev close $121.71
About EHC
- Employees
- 24,611
- Headquarters
- Birmingham, Alabama
- Listed
- Sep 24, 1986
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Website
- encompasshealth.com
EHC key statistics
- Market cap
- 12.00B
- Price-earnings ratio
- 19.82
- Dividend yield
- 0.63%
- Average volume
- 1.03M
- Volume
- 1.39M
- Open price
- $122.73
- High today
- $123.45
- Low today
- $119.77
- 52 Week high
- $129.96
- 52 Week low
- $92.77
Encompass Health (EHC) at a glance
As of Oct 20, 2026, Encompass Health (EHC) shares are priced at $121.67, giving the company a market cap of 12.00B, a price-to-earnings ratio of 19.82 and a dividend yield of 0.63%.
Today the stock has traded between $119.77 and $123.45. The current price is 1.6% above the day's low and 1.4% below its high.
Volume so far is 1.39M shares, above the average of 1.03M shares a day.
Over the past year Encompass Health has ranged from $92.77 to $129.96, and now sits 78% of the way up that range.
Encompass Health met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $1.55 per share against an estimate of $1.49.
The average analyst price target is $149.42, 22.8% above the current price, from 4 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 4 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 14 analystsAvg $149.42
- Low
- $127.58
- Now
- $121.67
- High
- $162.75
EHC earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 8 of the last 8 quarters, by 9.1% on average.
- Q3 FY24: reported $1.03 per share against an estimate of $0.9523
- Q4 FY24: reported $1.17 per share against an estimate of $1.04
- Q1 FY25: reported $1.37 per share against an estimate of $1.20
- Q2 FY25: reported $1.40 per share against an estimate of $1.22
- Q3 FY25: reported $1.23 per share against an estimate of $1.21
- Q4 FY25: reported $1.46 per share against an estimate of $1.31
- Q1 FY26: reported $1.60 per share against an estimate of $1.51
- Q2 FY26: reported $1.55 per share against an estimate of $1.49
EHC news
- Press releasePRNewswire
Encompass Health Rehabilitation Hospital of Bangor now open in Maine
- Press releasePRNewswire
Encompass Health announces date of 2026 third-quarter earnings call
- Press releasePRNewswire
Encompass Health expands in Montgomery County, Texas, with first small-format hospital, replacement hospital
- Press releasePRNewswire
Encompass Health Rehabilitation Hospital of Lower Providence now open in Pennsylvania
- Press releasePRNewswire
Encompass Health prices private offering of additional 5.875% senior notes due 2034
- Press releasePRNewswire
Encompass Health announces launch of private offering of 5.875% senior notes due 2034
- Press releasePRNewswire
Encompass Health reports results for second quarter 2026
Similar companies
Companies in the same industry as Encompass Health
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.